You just read:

Pearl Therapeutics to Present Complete PT003 Results from Phase 2b COPD Study in a Late-Breaker Session at the American Thoracic Society Annual Meeting

News provided by

Pearl Therapeutics

Apr 29, 2011, 09:00 ET